Showing results (121-130 of 905) with videos related to

Sort By:
Pageof 91
European Journal of Heart Failure|April 13, 2017
Tailoring mineralocorticoid receptor antagonist therapy in heart failure patients: are we moving towards a personalized approach?João Pedro Ferreira, Robert J Mentz, Anne Pizard, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 8, 2020
Prognostic impact of plasma volume estimated from hemoglobin and hematocrit in heart failure with preserved ejection fractionMasatake Kobayashi, Nicolas Girerd, Kevin Duarte, et al.
Journal of the American College of Cardiology|August 23, 2003
Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD)Michael Domanski, James Norman, Bertram Pitt, et al.
European Journal of Pharmacology|March 5, 2021
Potential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19Bertram Pitt, Nadia R Sutton, Zhong Wang, et al.
Journal of the American College of Cardiology|July 30, 2025
Aldosterone and Aldosterone Modulation in Cardio-Kidney DiseasesFrancesco Fioretti, Jeffrey M Testani, Maria Clarissa Tio, et al.
JACC. Heart Failure|March 5, 2018
Sudden Death in Heart Failure With Preserved Ejection Fraction: A Competing Risks Analysis From the TOPCAT TrialMuthiah Vaduganathan, Brian L Claggett, Neal A Chatterjee, et al.
JACC. Heart Failure|July 16, 2018
Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The TOPCAT TrialMaja Cikes, Brian Claggett, Amil M Shah, et al.
Archives of Internal Medicine|March 25, 2009
Red blood cell distribution width and mortality risk in a community-based prospective cohortTodd S Perlstein, Jennifer Weuve, Marc A Pfeffer, et al.
Pageof 91